THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: change in inventories

What this measure means

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Exact concept: us-gaap:IncreaseDecreaseInInventories. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: total assets
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: total liabilities
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: stockholders equity
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: cash and cash equivalents
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: net income or loss
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: operating cash flow
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: capital expenditure payments
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: revenue
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: contract revenue excluding tax
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: financing cash flow
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: investing cash flow
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: retained earnings or deficit
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: basic weighted-average shares
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: income tax expense or benefit
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: net property, plant and equipment
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: share-based compensation expense
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: operating income or loss
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: current assets
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: interest expense
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: current liabilities
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: current accounts payable
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: net finite-lived intangible assets
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: net current accounts receivable
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: operating expenses
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: net inventory
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: gross profit
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: research and development expense
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: common shares outstanding
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: cash including restricted cash
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: additional paid-in capital
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: total equity including noncontrolling interests
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: operating lease right-of-use asset
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: operating lease liability
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: long-term debt
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: gross property, plant and equipment
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: accumulated depreciation on property, plant and equipment
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: other noncurrent assets
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: accrued current liabilities
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: prepaid expenses and other current assets
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: pre-tax income or loss from continuing operations
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: profit or loss including noncontrolling interests
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: general and administrative expense
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: depreciation expense
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: depreciation, depletion and amortization
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: amortization of intangible assets
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: other nonoperating income or expense
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: nonoperating income or expense
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: interest paid, net
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: income taxes paid, net
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: proceeds from issuing common stock
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: change in accounts receivable
• THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: change in accounts payable

Inspect the source

Entity

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. / CIK 0001419051

Captured

2026-09-21T17:19:45.690Z

SEC response SHA-256

ad44380627053f8e0101ecf19c259e20a0a85d4c20ee53d5400d9dcf00541fc2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001419051.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))